Shanghai Kinetic Medical Co., Ltd (300326.SZ)
CNY 6.83
(1.19%)
CNY 6.83
(1.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 949.29 Million | 1.16 Billion | 1.26 Billion | 1.06 Billion | 1.22 Billion | 930.9 Million |
| Cost of Revenue | 504.81 Million | 422.66 Million | 483.31 Million | 354.47 Million | 418.71 Million | 368.71 Million |
| Gross Profit | 444.47 Million | 743.37 Million | 785.26 Million | 707.09 Million | 803.57 Million | 562.19 Million |
| Operating Expenses | 364.7 Million | 489.81 Million | 442.77 Million | 409.1 Million | 404.4 Million | 351.06 Million |
| Selling, General and Administrative Expenses | 309.57 Million | 318.77 Million | 308.16 Million | 314.03 Million | 297.86 Million | 260.17 Million |
| Research and Development Expenses | 59.34 Million | 61.4 Million | 69.77 Million | 46.64 Million | 48.67 Million | 43.46 Million |
| Other Expenses | -934.4 Thousand | -20.61 Million | 32.78 Million | 1.45 Million | 509.81 Thousand | -174.38 Thousand |
| Cost and Expenses | 816.18 Million | 912.48 Million | 926.09 Million | 763.58 Million | 823.11 Million | 719.77 Million |
| Operating Income | 140.07 Million | 97.69 Thousand | 218.77 Million | -87.19 Million | 359.22 Million | 497.62 Million |
| Interest Expense | 6.56 Million | 14.11 Million | 22.66 Million | 22.38 Million | 28.85 Million | 22.17 Million |
| Income Tax Expense | 6.97 Million | 21.68 Million | 41.31 Million | 37.68 Million | 55.61 Million | 37.08 Million |
| Earnings before Tax | 133.57 Million | -2.26 Million | 216.31 Million | -87.26 Million | 358.7 Million | 497.44 Million |
| Net Income | 112.53 Million | -21.28 Million | 161.77 Million | -126.53 Million | 302.32 Million | 462.56 Million |
| Earnings Per Share Basic | 0.16 | -0.03 | 0.22 | -0.18 | 0.42 | 0.64 |
| Earnings Per Share Diluted | 0.16 | -0.03 | 0.22 | -0.18 | 0.42 | 0.64 |
| Weighted Average Shares Outstanding | 716.79 Million | 719 Million | 721.89 Million | 702.98 Million | 721.71 Million | 717.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 716.79 Million | 719 Million | 721.89 Million | 702.98 Million | 721.71 Million | 718.49 Million |
| Gross Margin | 0.47 | 0.64 | 0.62 | 0.67 | 0.66 | 0.60 |
| EBIT Margin | 0.25 | 0.42 | 0.48 | 0.33 | 0.37 | 0.60 |
| Profit Margin | 0.12 | -0.02 | 0.13 | -0.12 | 0.25 | 0.50 |
| EBITDA | 235.76 Million | 107.22 Million | 318.78 Million | -17.48 Million | 428.67 Million | 561.98 Million |
| Earnings Before Tax Margin | 0.15 | 0.00 | 0.17 | -0.08 | 0.29 | 0.53 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 274.33 Million | 228.21 Million | 244.95 Million | 217.29 Million | 949.29 Million | 213.83 Million |
| Cost of Revenue | 148.98 Million | 117.08 Million | 126.76 Million | 133.91 Million | 504.81 Million | 91.39 Million |
| Gross Profit | 125.34 Million | 111.12 Million | 118.18 Million | 83.38 Million | 444.47 Million | 122.44 Million |
| Operating Expenses | 89.45 Million | 83.79 Million | 98.35 Million | 109.14 Million | 364.7 Million | 96.26 Million |
| Selling, General and Administrative Expenses | 176.75 Million | 71.04 Million | 83.37 Million | 89.71 Million | - | 133.58 Million |
| Research and Development Expenses | 13.44 Million | 12.77 Million | 14.97 Million | 18.49 Million | - | 15.47 Million |
| Other Expenses | -100.73 Million | 26.15 Thousand | -21.06 Thousand | -934.39 Thousand | -934.4 Thousand | 193.31 Thousand |
| Cost and Expenses | 238.43 Million | 200.87 Million | 225.11 Million | 243.06 Million | 869.51 Million | 187.65 Million |
| Operating Income | 36.57 Million | 27.33 Million | 19.83 Million | -25.76 Million | 79.77 Million | 22.06 Million |
| Interest Expense | 1.95 Million | 1.22 Million | 1.32 Million | 886.53 Thousand | 6.56 Million | 1.93 Million |
| Income Tax Expense | 6.35 Million | 3.47 Million | 3.03 Million | -8.35 Million | 6.97 Million | 3.2 Million |
| Earnings before Tax | 36.24 Million | 32.28 Million | 24 Million | -21.84 Million | 146.95 Million | 22.26 Million |
| Net Income | 25.82 Million | 19.36 Million | 10.87 Million | -16.62 Million | 112.53 Million | 14.45 Million |
| Earnings Per Share Basic | 0.04 | 0.03 | 0.02 | -0.02 | - | 0.02 |
| Earnings Per Share Diluted | 0.04 | 0.03 | 0.02 | -0.02 | - | 0.02 |
| Weighted Average Shares Outstanding | 717.02 Million | 717.02 Million | 717.02 Million | 717.02 Million | 717.02 Million | 717.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 717.02 Million | 717.02 Million | 717.02 Million | 717.02 Million | 717.02 Million | 717.02 Million |
| Gross Margin | 0.46 | 0.49 | 0.48 | 0.38 | 0.47 | 0.57 |
| EBIT Margin | 0.14 | 0.20 | 0.08 | -0.02 | - | 0.13 |
| Profit Margin | 0.09 | 0.08 | 0.04 | -0.08 | 0.12 | 0.07 |
| EBITDA | 38.19 Million | 46.75 Million | 20.33 Million | -4.27 Million | - | 27.01 Million |
| Earnings Before Tax Margin | 0.13 | 0.12 | 0.08 | -0.12 | 0.08 | 0.10 |
002119
RHIM
HFCL
GBLX
MOTILALOFS
SVRS